This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CHPA Applauds Governor Mike Pence And The Passage Of SB 496

WASHINGTON, May 8, 2013 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement a day after Governor Mike Pence signed into law Senate Bill 496 -- legislation authored by Senator Carlin Yoder (R-12) -- that takes a number of steps to tighten the state's existing meth laws.

"We commend Senator Yoder, Governor Pence, and the entire General Assembly for passing one of the strongest anti-meth bills in the nation," said Carlos Gutierrez, senior director of state government affairs for CHPA. "While we recognize that this annual limit may impact a small minority of responsible consumers who suffer from severe allergies, it makes it more difficult for meth cooks to skirt the law while preserving access to these medicines for the large majority of Hoosier families."

Specifically, the legislation:
  • Makes it a felony for an individual to engage in "smurfing" -- the criminal process of buying PSE-based products and selling them to a meth cook or dealer;
  • Requires all sales of pseudoephedrine -- including convenience-size packages -- to be registered via the NPLEx system;
  • Prevents prior methamphetamine offenders from being able to purchase PSE-containing medicines for seven years; and
  • Implements a 29% reduction in the amount a person can buy to 61.2 grams per year. 

"There is no question that Indiana, like many other parts of the country, continues to face an uphill battle against meth production and abuse," Gutierrez continued. "But I am confident that with strengthened legislation like Sen. Yoder's bill we will make real progress against meth criminals."

CHPA is the 132-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

chpa-info.org

SOURCE Consumer Healthcare Products Association

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs